TFFP TFF Pharmaceuticals
- 2.0200
- +0.0100+0.50%
TFF Pharmaceuticals News
TFF Group (TFF) Gets a Buy From Kepler Capital
Buy Rating Affirmed for TFF Pharmaceuticals Amid Strong Clinical Data and Market Potential
Analysts' Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)
TFF Pharmaceuticals Analyst Ratings
Positive Phase II Results Bolster Buy Rating for TFF Pharmaceuticals With Raised Price Target
Buy Rating Reaffirmed for TFF Pharmaceuticals: Promising Clinical Trials and Sufficient Funding Forecasted
TFF Pharmaceuticals (TFFP) Receives a Buy From JonesTrading
Analysts' Top Healthcare Picks: TFF Pharmaceuticals (TFFP), Cidara Therapeutics (CDTX)
HC Wainwright Adjusts Price Target on TFF Pharmaceuticals to $4 From $22, Maintains Buy Rating
HC Wainwright & Co. Maintains Buy on TFF Pharmaceuticals, Lowers Price Target to $4
Analysts Conflicted on These Healthcare Names: Crispr Therapeutics AG (CRSP), Haemonetics (HAE) and TFF Pharmaceuticals (TFFP)
JonesTrading Initiates Coverage On TFF Pharmaceuticals With Buy Rating, Announces Price Target of $7
Analysts Offer Insights on Healthcare Companies: Selecta Biosciences (SELB) and TFF Pharmaceuticals (TFFP)
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TFF Pharmaceuticals (TFFP) and Acurx Pharmaceuticals (ACXP)
HC Wainwright & Co. Reiterates Buy on TFF Pharmaceuticals, Maintains $22 Price Target
Maxim Group Keeps Their Buy Rating on TFF Pharmaceuticals (TFFP)
Maxim Group Remains a Buy on TFF Pharmaceuticals (TFFP)
TFF Pharmaceuticals (TFFP) Gets a Buy From Maxim Group
H.C. Wainwright Reaffirms Their Buy Rating on TFF Pharmaceuticals (TFFP)
Analysis
Price Target
No Data
